Forever You

Evolus Inc. is a performance beauty company focusing on an aesthetics portfolio of consumer brands within the cash-pay aesthetics market. The company's flagship product, Jeuveau, is a proprietary neurotoxin designed to temporarily improve the appearance of moderate to severe frown lines in adults, and has been recognized as the fastest-growing neurotoxin in the U.S. for four consecutive years.

In addition to Jeuveau, Evolus plans to launch Evolysse, a next-generation injectable hyaluronic acid made with ColdX Technology, set to debut in 2025. The company emphasizes a customer-centric approach by moving away from traditional reimbursement models to provide greater value to its partners and consumers.

Generated from the website